Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to $1.6 million.

  • Abvc Biopharma's Enterprise Value rose 24709.17% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 24709.17%. This contributed to the annual value of -$1.4 million for FY2024, which is 3426.12% down from last year.
  • Per Abvc Biopharma's latest filing, its Enterprise Value stood at $1.6 million for Q3 2025, which was up 24709.17% from $1.4 million recorded in Q2 2025.
  • Abvc Biopharma's Enterprise Value's 5-year high stood at $1.8 million during Q1 2025, with a 5-year trough of -$6.6 million in Q4 2021.
  • For the 5-year period, Abvc Biopharma's Enterprise Value averaged around -$1.7 million, with its median value being -$1.4 million (2024).
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 51066.88% in 2021, then skyrocketed by 24709.17% in 2025.
  • Over the past 5 years, Abvc Biopharma's Enterprise Value (Quarter) stood at -$6.6 million in 2021, then surged by 79.99% to -$1.3 million in 2022, then grew by 23.5% to -$1.0 million in 2023, then tumbled by 34.26% to -$1.4 million in 2024, then skyrocketed by 215.75% to $1.6 million in 2025.
  • Its Enterprise Value stands at $1.6 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.8 million for Q1 2025.